HSCSWHeartSciences Inc.
0.0420USD+3.45%Mkt Cap: —P/E: —4d ago
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-EC…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)4.32K $
Gross Profit2.55K $
Net Income (TTM)-9.14M $
Revenue/Share0.0020 USD
Last Price0.0420 USD
Fiscal Year End—
MR Quarter—
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.59
EPS (TTM)-1.09
EPS (Forward)—
52W Range
0.03855% of range0.1094
52W High0.1094 USD
52W Low0.0385 USD
Profitability
Gross Margin59.06%
Oper. Margin-194787.38%
EBITDA Margin0.00%
Profit Margin-211666.47%
ROE-4044.00%
ROA-173.71%
Growth
Revenue Growth-100.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.43M $
CapEx (TTM)44.45K $
FCF Margin-66454.62%
FCF Yield—
Net Debt2.28M $
Net Debt/EBITDA-0.27
Balance Sheet
Debt/Equity17.41
Current Ratio0.53
Quick Ratio0.34
Book Value/Sh0.0710 USD
Cash/Share0.4250 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float3.13M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta1.80
S&P 52W Chg18.16%
Avg Vol (30d)3.57K
Avg Vol (10d)—
Technical Indicators
RSI (14)40.4
MACD-0.0060
MACD Signal-0.0034
MACD Hist.-0.0026
BB Upper0.0846 USD
BB Middle0.0607 USD
BB Lower0.0367 USD
BB Width79.02%
ATR (14)0.0107 USD
Vol Ratio (20d)2.10x